Fig. 6From: NIR responsive tumor vaccine in situ for photothermal ablation and chemotherapy to trigger robust antitumor immune responsesa T1-weighted MR images of HA-PDA@IQ/DOX containing various Mn concentration. b T1-weighted MR images of HA-PDA@IQ/DOX HG at the tumor site. c T1-weighted images of HA-PDA@IQ/DOX and HA-PDA@IQ/DOX HG retention in the tumor site within 48 hBack to article page